Palo Alto Investors LP
PALO ALTO, CA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$672.2M2026 Q3
Positions56
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.59.9%
Top Holdings
PTCT
PTC Therapeutics
8.4%
IOVA
Iovance Biotherapeutics
7.7%
INSM
Insmed
7.5%
ACAD
Acadia Pharmaceuticals
7.5%
BMRN
Biomarin Pharmaceutical
5.7%
MIRM
Mirum Pharmaceuticals
4.9%
UTHR
United Therapeutics
4.7%
DYN
Dyne Therapeutics
4.5%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.